ABERA BIOSCIENCE AB (8WK) — Working Capital to Net Assets Ratio
ABERA BIOSCIENCE AB (8WK) has a Working Capital to Net Assets ratio of 86.7% as of March 2026. Working capital of €20.36 Million (current assets of €27.92 Million minus current liabilities of €7.57 Million) is measured against net assets of €23.48 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
ABERA BIOSCIENCE AB Working Capital to Net Assets (2022–2025)
This chart shows how ABERA BIOSCIENCE AB's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2026, the ratio stands at 86.7%, reflecting working capital of €20.36 Million against net assets of €23.48 Million EUR. For the complete balance sheet picture, see ABERA BIOSCIENCE AB (8WK) total assets.
Annual Working Capital to Net Assets for ABERA BIOSCIENCE AB (2022–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for ABERA BIOSCIENCE AB from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read debt load of ABERA BIOSCIENCE AB for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 83.4% | €16.09 Million | €19.29 Million | €25.37 Million | €9.28 Million | ▲ +17.6 pp |
| 2024 | 65.9% | €5.70 Million | €8.66 Million | €10.65 Million | €4.95 Million | ▼ -0.8 pp |
| 2023 | 66.6% | €3.77 Million | €5.66 Million | €7.46 Million | €3.69 Million | ▼ -22.1 pp |
| 2022 | 88.7% | €14.89 Million | €16.78 Million | €17.69 Million | €2.80 Million | — |